Although local treatment using corticosteroid eye drops is sufficient in a proportion of uveitis patients, wider use of methotrexate and biologics such as anti-TNF alpha monoclonal antibodies has been associated with marked improvement in controlling uveitis activity in more severe or persistently active cases. The gene discussed is TNF; the disease is uveitis.